Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines
- Supplementary File 1:
DOCX-Document (DOCX, 3598 KiB)
Yang, X.; Wang, S.; Trangle, S.S.; Li, Y.; White, W.L.; Li, J.; Ying, T.; Kong, Q.; Zhao, Y.; Lu, J. Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines. Mar. Drugs 2018, 16, 454. https://doi.org/10.3390/md16110454
Yang X, Wang S, Trangle SS, Li Y, White WL, Li J, Ying T, Kong Q, Zhao Y, Lu J. Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines. Marine Drugs. 2018; 16(11):454. https://doi.org/10.3390/md16110454
Chicago/Turabian StyleYang, Xu, Sheng Wang, Sari S. Trangle, Yan Li, William L. White, Jinyao Li, Tianlei Ying, Qingjun Kong, Yu Zhao, and Jun Lu. 2018. "Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines" Marine Drugs 16, no. 11: 454. https://doi.org/10.3390/md16110454


